Neural Omega
HealthOverviewOur approach to healthMaia CorpusFor patientsMaia ClinicalFor clinicians
ResearchOverviewOur approach to researchMAR PlatformFor researchersMassa SuiteFor pharma
CompanyAboutTeam and missionMimicryThe scienceEthicsHow we workObservatoryResearch and updates
Language
Contact

Ethics by design.

Grounded in
Bioethics and corporate responsibility
Applies to
Science, data, AI and the company
Led by
Chief Purpose Officer

How we think about the meeting point of science, artificial intelligence, the people whose health is at stake and the company we choose to be.

Behind every record is a person who chose to trust us with something intimate.

It can be done. Should it be?

Bioethics took shape in medicine and research in the second half of the twentieth century, out of a hard lesson: technical progress, on its own, says little about how people are treated. Its four principles anchor our work with patients, data and research.1

  • Autonomy

    Each person decides about their care, their data and their part in research.

  • Beneficence

    Every product and every study seeks a real benefit for patients.

  • Non‑maleficence

    Every action, in the clinic or in research, is weighed against the harm it could cause.

  • Justice

    Benefits, risks and access, in care and in science, are distributed fairly.

Neural Omega works with the most delicate material there is: the health of real people. We support it in clinical practice and study it in biomedical research, with digital infrastructure on their data and computational models to investigate it. Each of those steps holds an ethical decision, and so does every choice about how we are funded, who we partner with and what we say in public. We make each one deliberately.

Four fields. One duty.

Science, artificial intelligence, clinical data and the company itself meet in our work. Each brings its own duty.

  • Science

    From research we inherit the duty to claim exactly what the evidence supports. A strong hypothesis and a conclusion are different things, and keeping them apart matters to anyone looking for hope.

  • Artificial intelligence

    A model presents its results with a fluency that can read as certainty, and inherits the biases of its data. Its performance must be examined in every population it serves, starting with the least served.

  • Clinical data

    What a person shares about their illness is intimate and reaches us through trust. We treat it as a loan, held for the purpose it was given for and under the control of the person who shared it.2

  • The company

    How a company is funded, governed and run shapes what it can promise. We choose partners, funding and incentives aligned with the interests of the people we serve, and we hold ourselves to the same standard inside the company as outside it.

Proven in practice.

The ones that cost time, money or attention. These already guide how we work.

  1. 01

    We say what we can defend

    One register for everyone: what we would stand behind before a scientific reviewer is what we say in public. Every public claim matches its real level of validation, and credibility grows from claims that hold over time.

  2. 02

    Judgement stays with people

    Our models propose; experimental evidence and professional judgement decide. Technology is there to strengthen the relationship between patient and clinician, and when a feature invites more trust than the evidence supports, we limit it or remove it, however attractive it may be.

  3. 03

    Data is held in trust

    Personal clinical data is used only for the purpose it was given for, and the person keeps real control over it: to see it, take it with them and withdraw it. Data protection is the legal form of an earlier duty, loyalty to whoever trusted us.2

  4. 04

    We design for everyone affected

    Nearly four in five people with autoimmune disease are women, and innovation tends to reach the best-served first. We build with representativeness and access in mind from the first decision, and we measure our research by whether it becomes accessible solutions.3

Every day,again.

These tensions are resolved every day, in concrete decisions, and remain open to scrutiny. The commitment binds the team, the leadership and the founders alike.

What we promise is demanding: to keep these questions present in every decision, to accept being held to our own words, and to correct course whenever evidence, experience or error shows us we should.

Meetthe team.

Ethics is sustained by the people who make decisions every day. Meet who builds Neural Omega, and why.

  1. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. 8th ed. New York: Oxford University Press; 2019.
  2. Neural Omega processes personal health data in accordance with Regulation (EU) 2016/679 (General Data Protection Regulation), within the European Union.
  3. Estimate for the United States: 78.8% of people with autoimmune disease are women. Fairweather D, Rose NR. Women and autoimmune diseases. Emerg Infect Dis. 2004;10(11):2005–2011. doi:10.3201/eid1011.040367